Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Pentavalent Market Size Changed, over the years?

In recent times, there has been a progressive increase in the size of the pentavalent market. It’s projected to expand from $2.62 billion in 2024 to $2.73 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. This increase during the historic period can be credited to factors such as worldwide immunization efforts, governmental vaccine initiatives, prevention of various diseases, increased public health consciousness, as well as international collaborations and financial backing.

How Much Will the Pentavalent Market Be Worth in 2029?

The market size for pentavalent is predicted to experience consistent growth in the forthcoming years, escalating to $3.31 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. The expected growth during the forecasted period is due to ongoing worldwide immunization campaigns, amplification of vaccination programs, ventures into new territories, R&D efforts, and partnerships for vaccine accessibility. Key trends throughout the forecast period encompass worldwide health initiatives and financial backing, public enlightenment and educational initiatives, governmental regulations and policies, as well as advancements in vaccine production technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Which is the Largest Company in the Pentavalent Market?

Major companies operating in the pentavalent market include Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

What Are the Main Market Drivers in the Pentavalent Industry?

An increase in the occurrence of diphtheria is anticipated to propel the pentavalent market’s expansion. Diphtheria, a serious and highly infectious disease, is caused by the bacterium Corynebacterium diphtheriae. This disease can cause severe challenges with eating and breathing, as well as the potential for skin sores. The pentavalent vaccine, given in a 3-dose schedule as a pentavalent immunization, offers protection to children against diphtheria, this has escalated the demand for pentavalent vaccines due to the escalating prevalence of diphtheria. For example, in 2022, the World Health Organization (WHO), a United Nations specialized agency based in Switzerland, reported an unprecedented number of diphtheria cases primarily in June and August 2022 through the International Health Regulations (IHR) reporting system. Seven countries accounted for 144 reported diphtheria cases, with a considerable number amongst refugees. Of the 144 cases, 97 (69%) were found to be clinically comparable, 44 (31%) were confirmed as toxigenic diphtheria cases by laboratory tests, and 3 (2%) were suspected cases. Consequently, the growing prevalence of diphtheria is fuelling the pentavalent market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9104&type=smp

How Is the Pentavalent Market Segments Structured?

The pentavalent market covered in this report is segmented –

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Sodium Stibogluconate: Injectable Form, Oral Form, Other Formulations

2) By Meglumine Antimoniate: Injectable Form, Oral Form, Other Formulations

What Strategic Trends Are Transforming the Pentavalent Market?

A significant trend that’s gaining traction within the pentavalent market is product innovation. To consolidate their market position, major firms in this industry are focusing on the development of ground-breaking products. As an illustration, Pfizer, a pharmaceutical company based in the US and active in the pentavalent vaccines market, received approval in December 2022 from The United States Food and Drug Administration (a federal agency of the Department of Health and Human Services in the US) for their Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents. This vaccine is intended to prevent meningococcal disease in individuals aged between 10 to 25. What sets MenABCWY apart is its unique mix of components from two vaccines, ensuring protection against the leading causes of invasive meningococcal diseases.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Which Global Regions Offer the Highest Growth in the Pentavalent Market?

Asia-Pacific was the largest region in the pentavalent market in 2024. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9104

This Report Delivers Insight On:

1. How big is the pentavalent market, and how is it changing globally?

2. Who are the major companies in the pentavalent market, and how are they performing?

3. What are the key opportunities and risks in the pentavalent market right now?

4. Which products or customer segments are growing the most in the pentavalent market?

5. What factors are helping or slowing down the growth of the pentavalent market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model